{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382825896232412296.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Tetsuya Mitsudomi"}],"foaf:familyName":[{"@value":"Mitsudomi"}],"foaf:givenName":[{"@value":"Tetsuya"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362825896232412288","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1097/jto.0b013e31827ed0ff"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1556086415327738?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1556086415327738?httpAccept=text/plain"},{"@type":"PMID","@value":"23370315"}],"notation":[{"@value":"Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/jto.0b013e31827ed0ff_57PMRBzNC8gcMTxV0PrY3J7RhDB"}]}